Gilead Sciences, Inc. ( GILD) - Key Metrics

GILD Revenue per Share metrics
Date Revenue per Share Net Income per Share Operating Cash Flow Free Cash Flow per Share
2026Q2 $6.28 -$8.44 $2.87 $2.97
2026Q1 $5.60 $1.63 $2.05 $1.95
2025Q4 $6.38 $1.76 $2.68 $2.51
2025Q3 $6.25 $2.46 $3.30 $3.19
2025Q2 $5.69 $1.57 $0.66 $0.58

GILD Payout ratio and Price per Earnings ratio
Date Payout ratio PE ratio
2026Q2 -9.91% -3.74
2026Q1 51.46% 21.38
2025Q4 45.53% 17.43
2025Q3 32.93% 11.28
2025Q2 50.71% 17.65

GILD Free Cash Flow Yield and Dividend Yield
DateFree Cash Flow YieldDividend Yield
2026Q2 2.35% 0.66%
2026Q1 1.40% 0.60%
2025Q4 2.05% 0.65%
2025Q3 2.87% 0.73%
2025Q2 0.52% 0.72%

GILD

Price: $146.74

52 week price:
106.44
157.29

Dividend Yield: 2.42%

5-year range yield:
2.14%
5.18%

Forward Dividend Yield: 2.24%

Payout Ratio: 375.61%

Payout Ratio Range:
-69.01%
24533.33%

Dividend Per Share: 3.28 USD

Earnings Per Share: -2.65 USD

Exchange: NMS

Sector: Healthcare

Industry: Drug Manufacturers - General

Country: United States

Volume: 2.7 million

Ebitda: 2.4 billion

Market Capitalization: 165.0 billion

Average Dividend Frequency: 4

Years Paying Dividends: 12

DGR3: 2.70%

DGR5: 3.56%

DGR10: 30.00%

Links: